407 related articles for article (PubMed ID: 33426652)
1. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
Drake VE; Fakhry C; Windon MJ; Stewart CM; Akst L; Hillel A; Chien W; Ha P; Miles B; Gourin CG; Mandal R; Mydlarz WK; Rooper L; Troy T; Yavvari S; Waterboer T; Brenner N; Eisele DW; D'Souza G
Cancer; 2021 Apr; 127(7):1029-1038. PubMed ID: 33426652
[TBL] [Abstract][Full Text] [Related]
2. Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age.
Fakhry C; Waterboer T; Westra WH; Rooper LM; Windon M; Troy T; Koch W; Gourin CG; Bender N; Yavvari S; Kiess AP; Miles BA; Ryan WR; Ha PK; Eisele DW; D'Souza G
Oral Oncol; 2020 Feb; 101():104522. PubMed ID: 31881446
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of human papillomavirus and oropharyngeal cancer.
D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML
N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
[TBL] [Abstract][Full Text] [Related]
10. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.
Oliver SE; Gorbach PM; Gratzer B; Steinau M; Collins T; Parrish A; Kerndt PR; Crosby RA; Unger ER; Markowitz LE; Meites E
Sex Transm Dis; 2018 Oct; 45(10):660-665. PubMed ID: 30204745
[TBL] [Abstract][Full Text] [Related]
13. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer.
Anderson KS; Wong J; D'Souza G; Riemer AB; Lorch J; Haddad R; Pai SI; Longtine J; McClean M; LaBaer J; Kelsey KT; Posner M
Br J Cancer; 2011 Jun; 104(12):1896-905. PubMed ID: 21654689
[TBL] [Abstract][Full Text] [Related]
16. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.
D'Souza G; Gross ND; Pai SI; Haddad R; Anderson KS; Rajan S; Gerber J; Gillison ML; Posner MR
J Clin Oncol; 2014 Aug; 32(23):2408-15. PubMed ID: 24778397
[TBL] [Abstract][Full Text] [Related]
17. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.
Anderson KS; Gerber JE; D'Souza G; Pai SI; Cheng JN; Alam R; Kesiraju S; Chowell D; Gross ND; Haddad R; Gillison ML; Posner M
Oral Oncol; 2015 Aug; 51(8):751-8. PubMed ID: 26094591
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S;
J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239
[TBL] [Abstract][Full Text] [Related]
19. NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men.
Chaturvedi AK; Graubard BI; Broutian T; Pickard RK; Tong ZY; Xiao W; Kahle L; Gillison ML
Cancer Res; 2015 Jun; 75(12):2468-77. PubMed ID: 25873485
[TBL] [Abstract][Full Text] [Related]
20. Predictors of high-risk and low-risk oral HPV infection in the United States.
Orosco RK; Kedarisetty S; Hecht AS; Chang DC; Coffey CS; Weissbrod PA
Laryngoscope; 2016 Jun; 126(6):1365-72. PubMed ID: 26707355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
